The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
![Business Wire](../../../Content/images/providers/BW.png)
Annovis Bio, Inc. (ANVS)
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Annovis Bio, Inc. (“Annovis” or the “Company”) (NYSE: ANVS) on behalf of investors concerning the Company’s possible violations of federal securities laws.If you are a shareholder who suffered a loss, click here to participate.On April 29, 2024, Annovis announced that its Alzheimer’s drug, buntanetap, had shown significant results in a subgroup of patients. However, the subgroup was a fraction of the total planned patients, indicating that the drug failed to show statistical significance in meeting its endpoints.On this news, Annovis’s stock price fell $10.37, or 59.6%, to close at $7.28 per share on April 29, 2024, thereby injuring investors.Follow us for updates on Twitter: twitter.com/FRC_LAW.If you purchased Annovis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to
Show less
Read more
Impact Snapshot
Event Time:
ANVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANVS alerts
High impacting Annovis Bio, Inc. news events
Weekly update
A roundup of the hottest topics
ANVS
News
- Annovis Bio Files Patent for New Composition of Matter for Buntanetap [Yahoo! Finance]Yahoo! Finance
- Annovis Bio Files Patent for New Composition of Matter for BuntanetapGlobeNewswire
- Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson's Disease Data [Yahoo! Finance]Yahoo! Finance
- Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease DataGlobeNewswire
- Annovis Bio Highlights New Alzheimer's Data at the Alzheimer's Association International Conference® 2024 [Yahoo! Finance]Yahoo! Finance
ANVS
Earnings
- 5/10/24 - Beat
ANVS
Sec Filings
- 6/21/24 - Form S-8
- 6/13/24 - Form 8-K
- 6/11/24 - Form 8-K
- ANVS's page on the SEC website